Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer. Hamilton E, Pluard T, Wang JS, Morikawa A, et al. Breast Cancer Res 2025;27:151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hamilton E, Pluard T, Wang JS, Morikawa A, et al. Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer. Breast Cancer Res 2025;27:151.
PMID: 40830892